Do we really need prognostic factors for breast cancer? Gary M. Clark Plenary lecture, 15th Annual San Antonio Breast Cancer Symposium Pages: 117 - 126
Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer Leonardo FerrariNicoletta ZilemboAnna Maria Cerrotta Report Pages: 127 - 132
Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer Lazzaro RepettoLoredana MigliettaRiccardo Rosso Report Pages: 133 - 137
Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs G. R. RuttemanJ. A. FoekensW. Misdorp Report Pages: 139 - 146
Demonstration of gene-amplification by PCR in archival paraffin-embedded breast cancer tissue Ulf LönnSigrid LönnBjörn Stenkvist Report Pages: 147 - 152
Patterns of cyclic AMP binding in normal human breast S. BattersbyT. J. AndersonW. R. Miller Report Pages: 153 - 158
4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiatedin vitro Jann N. SarkariaElizabeth M. MillerR. Timothy Mulcahy Report Pages: 159 - 165
p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells Daniel EliyahuSteve EvansMarc Lippman Report Pages: 167 - 177
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer Michael A. LevesqueEleftherios P. DiamandisDonald J. A. Sutherland Report Pages: 179 - 195
Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels Arnon D. CohenYehuda ShoenfeldYoram Cohen Brief communication Pages: 197 - 200
The incidence of hepatocellular carcinoma in US white women with breast cancer after the introduction of tamoxifen in 1977 Kathrin MühlemannLinda S. CookNoel S. Weiss Brief communication Pages: 201 - 204
Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer Sheldon FineCharles ErlichmanTahany Gadalla Brief communication Pages: 205 - 209